πŸ‡ΊπŸ‡Έ FDA
Patent

US 8188219

Bone morphogenic protein binding peptide

granted A61KA61K35/32A61K38/10

Quick answer

US patent 8188219 (Bone morphogenic protein binding peptide) held by The Regents of the University of California expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/32, A61K38/10, A61K38/1709, A61K38/1841